Some of you may remember previous Articles that Dr. Ruslan Dorfman from GeneYouIn, also known as Pillcheck, completed for my Blog regarding Pharmacogenetic Testing. When he read my Blog last week he was kind enough to forward an article that he produced that speaks to who would be a good candidate for medical cannabis and I am happy to pass this article onto you.
The article is very interesting, since Dr. Dorfman addresses not only the cost of Medical Cannabis but the extremely complex manner of chronic pain, which can be the result of many conditions.
I have been following Pharmacogenetic Testing for a few years now and Dr. Dorfman is working with Green Shield to do further research.
A couple of my previous Blogs featuring Dr. Ruslan Dorfman:
- Can Pharmacogenetic Testing Shorten your Disability Leaves?
- Right Drug, Right Dose is Available Now
- Right Drug, Right Dose? The Perspective Expands – Part 4
- Right Drug, Right Dose? The Perspective Expands – Part 3
- Right Drug, Right Dose? The Perspective Expands – Part 2
- Right Drug, Right Dose? The Perspective Expands – Part 1
- Right Drug, Right Dose? The Perspective Expands
- Right Drug, Right Dose?
- Why is Genetic Testing Affecting your Insurance Premiums?
If you are looking for a Broker who is following the latest trends, contact Glendinning Insurance Services, your Resource Specialist.